Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Hank who wrote (2163)	2/2/2000 9:23:00 AM
From: DanZ	Read Replies (1) \| Respond to of 5582

The details of the study were not released pending publication. And yes, Hank. I'm truly a "dolt" when it comes to science and math. This explains how I earned an electrical engineering degree from one of the most difficult and prestigious engineering schools in the US. The market apparently agrees with my assessment of the business, which is more important in this case anyway. You and Wexler have apparently shorted GUMM based on a moral issue with the science. Wexler generalizes that all homeopathic remedies are snake oil and you are short, apparently because nobody has proven to you that Zicam works. This is kind of like shorting Philip Morris in the 1970s because you had a disdain for cigarette smoking or nobody proved to you that cigarette smoking was safe. Good luck. GUMM is bid at 35 on Instinet before the open. It looks like more institutions who see things differently than you are buying again. Dan